Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Received: 30 October 2020
Accepted: 26 March 2021
First Online: 7 April 2021
Consent for publication
: This paper is approved for publication by all authors and Malaysia Medical Research and Ethics Review Committee.
: AAS and HMI were appointed by Novartis for speaking engagement. The remaining authors declare no competing interests.